Halozyme Therapeutics HALO Q1 2026 Earnings EPS Beat Highlights Strong Operational Execution CVI Q1 2026 Earnings EPS Misses by Over 210 Amid Refining Headwinds LYB Q1 2026 Earnings Strong EPS Surprise of 140 as Cost Optimization Drives Results ZION Q1 2026 Earnings EPS Surpasses Estimates by Over 7 Amid Solid Operating Performance Benchmark Electronics BHE Q1 2026 Earnings EPS Surpasses Estimates as Shares Gain 325 HELE Q1 2026 Earnings EPS Beats Estimates Stock Gains